Catalyst Wire Dossier Catalyst Wire Dossier

Ofatumumab

ofatumumab · Novartis
Drug timelines are a Plus or Pro feature.

84 regulatory and trial events tracked for Ofatumumab, covering 2011-07-20 to 2026-04-29. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Ofatumumab and Siponimod Compared to Fingolimod in Pediatric Patients With Multiple Sclerosis [Phase 3]

See pricing